JPH027957B2 - - Google Patents

Info

Publication number
JPH027957B2
JPH027957B2 JP56175559A JP17555981A JPH027957B2 JP H027957 B2 JPH027957 B2 JP H027957B2 JP 56175559 A JP56175559 A JP 56175559A JP 17555981 A JP17555981 A JP 17555981A JP H027957 B2 JPH027957 B2 JP H027957B2
Authority
JP
Japan
Prior art keywords
tosylate
amino
composition according
crystalline
dioxopenicilanoyloxymethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP56175559A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57126493A (en
Inventor
Ore Gotsudofuretsudosen Bagun
Fuon Daeene Berufu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Publication of JPS57126493A publication Critical patent/JPS57126493A/ja
Publication of JPH027957B2 publication Critical patent/JPH027957B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP56175559A 1980-10-31 1981-10-30 Cryatal hydrate of penicillanic acid derivative salt, manufacture and use Granted JPS57126493A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8035156 1980-10-31

Publications (2)

Publication Number Publication Date
JPS57126493A JPS57126493A (en) 1982-08-06
JPH027957B2 true JPH027957B2 (en]) 1990-02-21

Family

ID=10517019

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56175559A Granted JPS57126493A (en) 1980-10-31 1981-10-30 Cryatal hydrate of penicillanic acid derivative salt, manufacture and use

Country Status (26)

Country Link
US (1) US4831025A (en])
JP (1) JPS57126493A (en])
KR (1) KR870001982B1 (en])
AT (1) AT373893B (en])
AU (1) AU543870B2 (en])
BE (1) BE890938A (en])
CA (1) CA1180696A (en])
CH (1) CH647527A5 (en])
DE (1) DE3143219A1 (en])
DK (1) DK154219C (en])
ES (1) ES8206531A1 (en])
FI (1) FI813331A7 (en])
FR (1) FR2493322B1 (en])
GB (1) GB2114969B (en])
GR (1) GR75369B (en])
IE (1) IE51640B1 (en])
IL (1) IL64009A (en])
IT (1) IT1193735B (en])
LU (1) LU83727A1 (en])
NL (1) NL8104938A (en])
NO (1) NO813683L (en])
NZ (1) NZ198622A (en])
PH (1) PH17820A (en])
PT (1) PT73913B (en])
SE (1) SE452322B (en])
ZA (1) ZA817091B (en])

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4432987A (en) * 1982-04-23 1984-02-21 Pfizer Inc. Crystalline benzenesulfonate salts of sultamicillin
PH20068A (en) * 1982-12-06 1986-09-18 Pfizer Process and intermediates for sultamicillin and analogs
KR910009271B1 (ko) * 1989-06-20 1991-11-08 김영설 1,1-디옥소페닐실라노일 옥시메틸 D-6-[α-(메틸렌아미노)페닐-아세트아미도]-페니실라네이트와 그의 파라-톨루엔술폰산염
ES2161602B1 (es) * 1999-04-08 2003-02-16 Asturpharma S A Sintesis de 6-(d-alfa-(bencilidenaminofenilacetamido))penicilanato de 1,1-dioxopenicilanoiloximetilo y analogos. nuevos intermedios para la sintesis de sultamicilina.
US6991807B2 (en) * 2000-02-24 2006-01-31 Advancis Pharmaceutical, Corp. Antibiotic composition
US6610328B2 (en) 2000-02-24 2003-08-26 Advancis Pharmaceutical Corp. Amoxicillin-clarithromycin antibiotic composition
US6627222B2 (en) 2000-02-24 2003-09-30 Advancis Pharmaceutical Corp. Amoxicillin-dicloxacillin antibiotic composition
US6667042B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Fluroquinilone antibiotic product, use and formulation thereof
US6663891B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Erythromyacin antibiotic product, use and formulation thereof
US6632453B2 (en) 2000-02-24 2003-10-14 Advancis Pharmaceutical Corp. Ciprofoxacin-metronidazole antibiotic composition
US7025989B2 (en) * 2000-02-24 2006-04-11 Advancis Pharmaceutical Corp. Multiple-delayed released antibiotic product, use and formulation thereof
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6623758B2 (en) 2000-02-24 2003-09-23 Advancis Pharmaceutical Corp. Cephalosporin-metronidazole antibiotic composition
US6667057B2 (en) 2000-02-24 2003-12-23 Advancis Pharmaceutical Corp. Levofloxacin antibiotic product, use and formulation thereof
EP1257255A4 (en) * 2000-02-24 2008-07-30 Advancis Pharmaceutical Corp THERAPEUTIC PRODUCT, ITS USE AND MANUFACTURE
US6565882B2 (en) 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6663890B2 (en) 2000-02-24 2003-12-16 Advancis Pharmaceutical Corp. Metronidazole antibiotic product, use and formulation thereof
US6669948B2 (en) 2000-02-24 2003-12-30 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6638532B2 (en) 2000-02-24 2003-10-28 Advancis Pharmaceutical Corp. Tetracycline—doxycycline antibiotic composition
US6730320B2 (en) 2000-02-24 2004-05-04 Advancis Pharmaceutical Corp. Tetracycline antibiotic product, use and formulation thereof
CA2400818C (en) * 2000-02-24 2009-01-06 Advancis Pharmaceutical Corporation Antibiotic and antifungal compositions
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US7105174B2 (en) * 2000-10-13 2006-09-12 Advancis Pharmaceutical Corporation Multiple-delayed release anti-neoplastic product, use and formulation thereof
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
US7157095B2 (en) * 2000-10-13 2007-01-02 Advancis Pharmaceutical Corporation Multiple-delayed release antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
US20040114368A1 (en) * 2002-12-13 2004-06-17 Shyu Shing Jy Light device having rotatable or movable view
WO2004104022A2 (en) * 2003-05-16 2004-12-02 The General Hospital Corporation Compositions comprising pathogen elicited epithelial chemoattractant (eicosanoid hepoxilin a3), inhibitors thereof and methods of use thereof
AU2004258953B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
EP1648418A4 (en) 2003-07-21 2011-11-16 Middlebrook Pharmaceuticals Inc ANTIBIOTIC PRODUCT, ITS USE AND FORMULATION
JP2006528189A (ja) 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質産物、その使用法および製剤
EP1653925A1 (en) 2003-08-11 2006-05-10 Advancis Pharmaceutical Corporation Robust pellet
US8062672B2 (en) 2003-08-12 2011-11-22 Shionogi Inc. Antibiotic product, use and formulation thereof
AU2004270170B2 (en) 2003-08-29 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
AU2004273830B2 (en) 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2572292A1 (en) 2004-07-02 2006-02-09 Advancis Pharmaceutical Corporation Tablet for pulsed delivery
WO2007004239A1 (en) * 2005-07-06 2007-01-11 Morepen Laboratories Limited New polymorphic form of sultamicillin tosylate and a process therefor
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) * 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US9452155B2 (en) 2012-07-17 2016-09-27 Bayer New Zealand Ltd Injectable antibiotic formulations and their methods of use
EP2874624B8 (en) 2012-07-17 2019-10-02 Bayer New Zealand Limited Injectable antibiotic formulations and their methods of use
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1532222A (fr) * 1963-10-28 1968-07-12 Bristol Myers Co Procédé de préparation de dérivés de la pénicilline
IE49881B1 (en) * 1979-02-13 1986-01-08 Leo Pharm Prod Ltd B-lactam intermediates
ZA80796B (en) * 1979-02-13 1981-02-25 Leo Pharm Prod Ltd Chemical compounds
US4244951A (en) * 1979-05-16 1981-01-13 Pfizer Inc. Bis-esters of methanediol with penicillins and penicillanic acid 1,1-dioxide
IE51516B1 (en) * 1980-10-06 1987-01-07 Leo Pharm Prod Ltd 1,1-dioxapenicillanoyloxymethyl 6-(d-alpha-amino-alpha-phenylacetamido)penicillanate napsylate

Also Published As

Publication number Publication date
NL8104938A (nl) 1982-05-17
AU543870B2 (en) 1985-05-09
NZ198622A (en) 1985-07-12
AU7636581A (en) 1982-05-06
DK154219B (da) 1988-10-24
DE3143219C2 (en]) 1990-05-17
DK472181A (da) 1982-05-01
IE51640B1 (en) 1987-01-21
NO813683L (no) 1982-05-03
PT73913A (en) 1981-11-01
GB2114969B (en) 1985-02-20
IL64009A (en) 1984-09-30
FI813331L (fi) 1982-05-01
CA1180696A (en) 1985-01-08
JPS57126493A (en) 1982-08-06
GB2114969A (en) 1983-09-01
IT8168383A0 (it) 1981-10-23
ES506751A0 (es) 1982-08-16
US4831025A (en) 1989-05-16
IL64009A0 (en) 1982-01-31
AT373893B (de) 1984-02-27
ES8206531A1 (es) 1982-08-16
FR2493322A1 (fr) 1982-05-07
ZA817091B (en) 1982-10-27
IE812361L (en) 1982-04-30
PT73913B (en) 1984-05-29
IT1193735B (it) 1988-08-24
FR2493322B1 (fr) 1986-06-13
CH647527A5 (de) 1985-01-31
DE3143219A1 (de) 1982-08-12
DK154219C (da) 1989-03-20
SE8106404L (sv) 1982-05-01
BE890938A (fr) 1982-04-30
KR870001982B1 (ko) 1987-10-24
KR830007671A (ko) 1983-11-04
PH17820A (en) 1985-01-07
GR75369B (en]) 1984-07-13
LU83727A1 (fr) 1982-05-07
FI813331A7 (fi) 1982-05-01
SE452322B (sv) 1987-11-23
ATA447781A (de) 1983-07-15

Similar Documents

Publication Publication Date Title
JPH027957B2 (en])
AU2002230217B2 (en) Tablets quickly disintegrated in oral cavity
HU190603B (en) Process for the production of /6r7r/-3-carbomoil-oxy-methyl-7- /1z/-2-2/fur-2-il/methoxy-imino-acet-amido/-cef-3-em-4-carboxylic acid-ester of new form
CA2420461C (en) Preparations for oral administration
ZA200005153B (en) Novel crystalline forms of an antiviral benzimidazole compound.
US4452800A (en) Salts of 3(n-butyl)-4-hydroxy-1-phenyl-1,8-naphthyridine-2(1H)-one and their use in treating chronic obstructive lung diseases
JPH04257587A (ja) 置換カルボン酸のコデイン塩
JPH04502462A (ja) 治療上活性な置換されたベンズイミダゾールおよびその製法
JPS59128383A (ja) 新規キノリンカルボン酸誘導体および該化合物を有効成分とする抗菌剤
JPH027956B2 (en])
RU2341529C2 (ru) Гликозидное пролекарство 5-аминосалициловой кислоты
GB2084572A (en) 1,1-Dioxopenicillanoyloxymethyl 6-(D- alpha -amino- alpha -phenylacetamido)penicillanate napsylate
EP2481395A1 (en) Sachet, effervescent tablet and dry syrup of otilonium
JP2003501354A (ja) アザビシクロ（２．２．２）オクタン−３−アミンクエン酸塩の結晶多形及びそれらの医薬組成物
JPH0296577A (ja) 新規な１，３，４‐チアジアゾール誘導体および該誘導体を有効成分とする抗潰瘍剤
HK1057712A (en) Tablets quickly disintegrated in oral cavity
JPS6052717B2 (ja) 抗菌剤